<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02181452</url>
  </required_header>
  <id_info>
    <org_study_id>LE1</org_study_id>
    <nct_id>NCT02181452</nct_id>
  </id_info>
  <brief_title>Liver Fibrosis Assessment With ShearWave Elastography</brief_title>
  <official_title>Evaluation of SWE Performances for the Non-Invasive Diagnosis of Liver Fibrosis in Patients With Chronic Liver Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SuperSonic Imagine</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Johann Wolfgang Goethe University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>SuperSonic Imagine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic liver disease/fibrosis can be the result of various causes, and the result is that
      the liver tissue becomes stiff. ShearWave™ elastography, available on the Aixplorer®
      ultrasound system, is a method that can be used to measure the stiffness of organs in the
      body, for example the liver.

      This study will evaluate how this technology performs as a non-invasive test to stage liver
      fibrosis in patients with chronic liver disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The measurements of liver stiffness made by the Aixplorer® will be compared to (where
      available) :

        -  blood markers

        -  biopsy results

        -  other stiffness measurement exams (FibroScan, ARFI, ElastPQ...)

      The influence of other (confounding) factors on the reliability of SWE measurements will be
      analyzed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">June 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation coefficients between factors and liver stiffness</measure>
    <time_frame>Within one year of the study start date</time_frame>
    <description>Factors include patient's clinical and biological parameters</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technical success rates depending on factors</measure>
    <time_frame>Within one year of the study start date</time_frame>
    <description>Factors include patient's clinical and biological parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diagnostic performance of multivariate models to assess liver fibrosis levels</measure>
    <time_frame>Within one year of the study start date</time_frame>
    <description>Determined by histological examination of liver biopsy. The resulting tests will be compared on the basis of their AUROC and test of statistical differences.
Fibrosis levels involved are:
at least significant fibrosis (Metavir score F≥2)
at least severe fibrosis (Metavir score F≥3)
liver cirrhosis (Metavir score F=4)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity, specificity, positive and negative predictive values of the best multivariate model to assess liver fibrosis</measure>
    <time_frame>Within one year of the study start date</time_frame>
    <description>This will be determined by histological examination of liver biopsy</description>
  </secondary_outcome>
  <enrollment type="Actual">2333</enrollment>
  <condition>Liver Fibrosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Population will consist of patients who have confirmed or suspected liver fibrosis and will
        be assessed with ultrasound, +/- blood analysis, +/- other non-invasive imaging, and/or
        measurements, and biopsy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients meeting a single condition below:

               -  Chronic hepatitis B, defined by serology HBsAg positive and the presence of DNA /
                  RNA in the serum, or

               -  Chronic hepatitis C, defined by serology anti-HCV positive and the presence of
                  DNA / RNA in the serum, or

               -  non-alcoholic fatty-liver disease

          -  And meeting all of the conditions below:

               -  liver biopsy for histological evaluation of liver fibrosis

               -  Length of liver biopsy ≥ 15 mm paraffin sections (except if cirrhosis)

               -  Age of majority in their country

               -  Obtaining the signature of consent for participation in the data collection, in
                  addition to the routine consent form routinely used at the sites.

        Exclusion Criteria:

          -  Cause of chronic liver disease other than viral (alcohol, hemochromatosis, autoimmune
             hepatitis, biliary tract disease intrahepatic...) and other than non-alcoholic
             fatty-liver disease

          -  History of antiviral therapy for 6 months or less of current antiviral therapy

          -  Any systemic, viral hepatitis and HIV co-infection

          -  Pregnant woman

          -  Failure to obtain consent

          -  Length of all liver biopsy specimens below 15mm
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mireen Freidrich-Rust</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johan Goethe University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Antwerp</name>
      <address>
        <city>Edegem</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>3rd Hospital of Sun Yat-sen University</name>
      <address>
        <city>Guangzhou, Guangdong</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Bordeaux</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beaujon Hospital</name>
      <address>
        <city>Clichy</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cochin Hospital</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Bonn</name>
      <address>
        <city>Bonn</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johan Goethe Universitat</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Athens Medical School</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chinese University of Hong Kong - Prince of Wales Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pavia</name>
      <address>
        <city>Pavia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Timosoara</name>
      <address>
        <city>Timisoara</city>
        <country>Romania</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>China</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Hong Kong</country>
    <country>Italy</country>
    <country>Romania</country>
  </location_countries>
  <removed_countries>
    <country>Israel</country>
  </removed_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 19, 2014</study_first_submitted>
  <study_first_submitted_qc>July 1, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 4, 2014</study_first_posted>
  <last_update_submitted>May 11, 2015</last_update_submitted>
  <last_update_submitted_qc>May 11, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 12, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>liver</keyword>
  <keyword>fibrosis</keyword>
  <keyword>ShearWave Elastography</keyword>
  <keyword>ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

